Long COVID in a prospective cohort of home-isolated patients

Nat Med. 2021 Sep;27(9):1607-1613. doi: 10.1038/s41591-021-01433-3. Epub 2021 Jun 23.

Abstract

Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized patients, but the spectrum of symptoms in milder cases needs further investigation. We conducted a long-term follow-up in a prospective cohort study of 312 patients-247 home-isolated and 65 hospitalized-comprising 82% of total cases in Bergen during the first pandemic wave in Norway. At 6 months, 61% (189/312) of all patients had persistent symptoms, which were independently associated with severity of initial illness, increased convalescent antibody titers and pre-existing chronic lung disease. We found that 52% (32/61) of home-isolated young adults, aged 16-30 years, had symptoms at 6 months, including loss of taste and/or smell (28%, 17/61), fatigue (21%, 13/61), dyspnea (13%, 8/61), impaired concentration (13%, 8/61) and memory problems (11%, 7/61). Our findings that young, home-isolated adults with mild COVID-19 are at risk of long-lasting dyspnea and cognitive symptoms highlight the importance of infection control measures, such as vaccination.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Ageusia / virology
  • Anosmia / virology
  • Antibodies, Viral / blood*
  • COVID-19 / complications*
  • COVID-19 / pathology*
  • Child
  • Child, Preschool
  • Cognitive Dysfunction / virology*
  • Dyspnea / virology*
  • Fatigue / virology*
  • Female
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Norway
  • Patient Isolation
  • Post-Acute COVID-19 Syndrome
  • Prospective Studies
  • SARS-CoV-2
  • Severity of Illness Index
  • Young Adult

Substances

  • Antibodies, Viral